. Immune checkpoint inhibitors are associated with a diverse spectrum of immune-related adverse events. In this case study, a 35-year-old female melanoma patient treated with ipilimumab, developed systemic inflammation and immune-related pneumonitis. . h
#cancer #inflammation #health This autopsy case illustrates that clinically overt immune-related adverse events may represent only a fraction of the total spectrum of immune-related organ pathology in patients treated with immune checkpoint inhibitors. .
Systemic inflammation in autopsy of skin #cancer patient treated with anti-CTLA4/PD1 who died of disease progression https://t.co/jX4ieI4zGf
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study https://t.co/DtlgAeNaz5 #jitc